<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-antioxidants-09-00660">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Petrosino</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Cordaro</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Verde</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Schiano Moriello</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Marcolongo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Schievano</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Siracusa</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Piscitelli</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Peritore</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>Crupi</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Oral Ultramicronized palmitoylethanolamide: Plasma and tissue levels and spinal anti-hyperalgesic effect</article-title>
  <source>Front. Pharmacol.</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>249</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2018.00249</pub-id>
  <pub-id pub-id-type="pmid">29615912</pub-id>
 </element-citation>
</ref>
